← Leaderboards
Jeffrey D Esko
University Of California San Diego
$29,504,748
Attributed
$34,910,264
Total exposure
25
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,910,264 · 25
By mechanism
R01$10,722,848 · 6
P01$9,524,084 · 5
K12$5,317,873 · 1
R37$3,895,064 · 1
U01$1,783,275 · 1
R21$1,381,132 · 4
Top collaborators
- Kamil Godula5 shared
- John Ravits5 shared
- Christina Sigurdson5 shared
- Ajit P Varki5 shared
- Kuo-Fen Lee1 shared
Others in their field
Top investigators on “Heparitin Sulfate”
- Pyong Woo Park · Baylor College Of Medicine$14,878,527
- Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute$12,341,999
- Vincent C. Hascall · Cleveland Clinic Foundation$11,439,932
- Jian None Liu · University Of North Carolina Chapel Hill$9,367,049
- Lianchun Wang · University Of Georgia$8,970,811
- Umesh Ramanlal Desai · Versiti Blood Health, Inc.$7,283,130
Research focus
Heparitin SulfateAffectCellsEnzymesPolysaccharidesIn VivoTissuesProteoglycanSulfotransferaseMutationHeparan Sulfate BiosynthesisResearch PersonnelStructureGenesInterestGlycosaminoglycansInflammationIn VitroMutantSulfationInsightBiologyFamilyBlood Vessels
Grant awards (102)
Mechanisms of Prion Aggregation$480,952
R01 · FY2025 · NS
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome$463,375
P01 · FY2025 · HL · contact PI
The Heparan Sulfate Landscape in Complement Regulation$231,345
R21 · FY2025 · AI · contact PI
Mechanisms of Prion Aggregation$480,834
R01 · FY2024 · NS
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome$455,737
P01 · FY2024 · HL · contact PI
Mechanisms of Prion Aggregation$480,718
R01 · FY2023 · NS
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome$463,382
P01 · FY2023 · HL · contact PI
UCSD Biomedical Scientist Career Development Program in Glycoscience$1,050,483
K12 · FY2022 · HL · contact PI
Mechanisms of Prion Aggregation$501,557
R01 · FY2022 · NS
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome$463,385
P01 · FY2022 · HL · contact PI
UCSD Biomedical Scientist Career Development Program in Glycoscience$1,054,953
K12 · FY2021 · HL · contact PI
Mechanisms of Prion Aggregation$501,375
R01 · FY2021 · NS
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome$473,403
P01 · FY2021 · HL · contact PI
UCSD Biomedical Scientist Career Development Program in Glycoscience$1,062,512
K12 · FY2020 · HL · contact PI
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis$532,405
P01 · FY2020 · HL · contact PI
UCSD Biomedical Scientist Career Development Program in Glycoscience$1,069,925
K12 · FY2019 · HL · contact PI
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis$532,405
P01 · FY2019 · HL · contact PI
Enhancement of wound healing and regeneration through heparan sulfate deficiency$391,673
R33 · FY2019 · AR · contact PI
Genetic analysis of proteoglycan-mediated lipoprotein clearance$370,452
R01 · FY2019 · GM · contact PI
UCSD Biomedical Scientist Career Development Program in Glycoscience$1,080,000
K12 · FY2018 · HL · contact PI
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis$532,405
P01 · FY2018 · HL · contact PI
Glycosylation of the perineuronal net in Alzheimer's Disease$459,954
R56 · FY2018 · AG
Genetic analysis of proteoglycan-mediated lipoprotein clearance$370,453
R01 · FY2018 · GM · contact PI
Enhancement of wound healing and regeneration through heparan sulfate deficiency$368,745
R61 · FY2018 · AR · contact PI
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis$532,412
P01 · FY2017 · HL · contact PI
Enhancement of wound healing and regeneration through heparan sulfate deficiency$384,245
R61 · FY2017 · AR · contact PI
Genetic analysis of proteoglycan-mediated lipoprotein clearance$370,453
R01 · FY2017 · GM · contact PI
Drug Discovery for Multiple Hereditary Exostoses$345,284
R01 · FY2017 · AR · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$268,188
P01 · FY2017 · HL · contact PI
Glycosciences Skills Development$98,511
P01 · FY2017 · HL · contact PI
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis$541,560
P01 · FY2016 · HL · contact PI
Genetic analysis of proteoglycan-mediated lipoprotein clearance$370,453
R01 · FY2016 · GM · contact PI
Drug Discovery for Multiple Hereditary Exostoses$292,107
R01 · FY2016 · AR · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$265,134
P01 · FY2016 · HL · contact PI
Genome-wide Analysis of Heparan Sulfate using CRISPR/Cas9$168,563
R21 · FY2016 · CA · contact PI
Glycosciences Skills Development$94,317
P01 · FY2016 · HL · contact PI
Drug Discovery for Multiple Hereditary Exostoses$53,177
R01 · FY2016 · AR · contact PI
5th International MHE Research Conference$25,000
R13 · FY2016 · AR · contact PI
Drug Discovery for Multiple Hereditary Exostoses$397,898
R01 · FY2015 · AR · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$254,561
P01 · FY2015 · HL · contact PI
Genome-wide Analysis of Heparan Sulfate using CRISPR/Cas9$202,275
R21 · FY2015 · CA · contact PI
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance$148,055
R01 · FY2015 · GM · contact PI
Glycosciences Skills Development$88,469
P01 · FY2015 · HL · contact PI
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance$444,166
R01 · FY2014 · GM · contact PI
Drug Discovery for Multiple Hereditary Exostoses$376,968
R01 · FY2014 · AR · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$243,446
P01 · FY2014 · HL · contact PI
Glycosciences Skills Development$84,603
P01 · FY2014 · HL · contact PI
Drug Discovery for Multiple Hereditary Exostoses$443,359
R01 · FY2013 · AR · contact PI
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance$428,084
R01 · FY2013 · GM · contact PI
Structure and Function of 3-O-sulfation in Heparan Sulfate$270,636
R01 · FY2013 · GM · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$230,290
P01 · FY2013 · HL · contact PI
Glycosciences Skills Development$79,724
P01 · FY2013 · HL · contact PI
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance$442,205
R01 · FY2012 · GM · contact PI
Structure and Function of 3-O-sulfation in Heparan Sulfate$294,586
R01 · FY2012 · GM · contact PI
Genetic Analysis of Heparan Sulfate in Vascular Biology$289,383
P01 · FY2012 · HL · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$209,241
P01 · FY2012 · HL · contact PI
Glycosciences Skills Development$86,275
P01 · FY2012 · HL · contact PI
Genetic Analysis of Proteoglycan-Mediated Lipoprotein Clearance$441,086
R01 · FY2011 · GM · contact PI
Structure and Function of 3-O-sulfation in Heparan Sulfate$308,365
R01 · FY2011 · GM · contact PI
Genetic Analysis of Heparan Sulfate in Vascular Biology$289,383
P01 · FY2011 · HL · contact PI
Gene Discovery and Heparan Sulfate Biogenesis$193,125
R21 · FY2011 · HL · contact PI
Genetic Analysis of Glycosaminoglycans in Inflammatory Responses$187,314
P01 · FY2011 · HL · contact PI
Glycosciences Skills Development$89,197
P01 · FY2011 · HL · contact PI
Structure and Function of 3-O-sulfation in Heparan Sulfate$333,720
R01 · FY2010 · GM · contact PI
Genetic Analysis of Heparan Sulfate in Vascular Biology$289,383
P01 · FY2010 · HL · contact PI
Gene Discovery and Heparan Sulfate Biogenesis$237,930
R21 · FY2010 · HL · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$102,023
R37 · FY2010 · GM · contact PI
Shared Instrumentation Grant: LTQ Linear Ion Trap Mass Spectrometer$420,055
S10 · FY2009 · RR · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$403,993
R37 · FY2009 · GM · contact PI
Genetic Analysis of Heparan Sulfate in Vascular Biology$289,383
P01 · FY2009 · HL · contact PI
Glycoside Inhibitors of Tumor Metastasis$285,973
R01 · FY2009 · CA · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$396,629
R37 · FY2008 · GM · contact PI
Genetic Analysis of Heparan Sulfate in Vascular Biology$289,383
P01 · FY2008 · HL · contact PI
Glycoside Inhibitors of Tumor Metastasis$279,017
R01 · FY2008 · CA · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$401,021
R37 · FY2007 · GM · contact PI
Glycoside Inhibitors of Tumor Metastasis$306,588
R01 · FY2007 · CA · contact PI
Genetic analysis of heparan sulfate in vascular biology$284,816
P01 · FY2007 · HL · contact PI
Altered endothelial heparan sulfate causes diaphragmatic hernias resembling CDH$155,645
R21 · FY2007 · HD · contact PI
IDENTIFICATION OF NOVEL CHONDROITIN PROTEOGLYCANS IN CAENORHABDITIS ELEGANS$6,224
P41 · FY2007 · RR · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$401,664
R37 · FY2006 · GM · contact PI
Glycoside Inhibitors of Tumor Metastasis$308,446
R01 · FY2006 · CA · contact PI
Altered endothelial heparan sulfate/diaphragmatic hernia$192,249
R21 · FY2006 · HD · contact PI
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$398,216
R37 · FY2005 · GM
Glycoside Inhibitors of Tumor Metastasis$321,160
R01 · FY2005 · CA
Heparan Sulfate--a Novel Target for Cancer Therapeutics$453,041
U01 · FY2004 · CA
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$343,668
R37 · FY2004 · GM
Heparan Sulfate--a Novel Target for Cancer Therapeutics$465,503
U01 · FY2003 · CA
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$358,785
R37 · FY2003 · GM
Genetic analysis of heparan sulfate in vascular biology$237,880
P01 · FY2003 · HL
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$40,000
R37 · FY2003 · GM
Heparan Sulfate--a Novel Target for Cancer Therapeutics$428,329
U01 · FY2002 · CA
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$368,026
R37 · FY2002 · GM
SELECTIN/HEPARAN SULFATE INTERACTIONS IN ACUTE LUNG INJURY$40,863
P50 · FY2002 · HL
Heparan Sulfate--a Novel Target for Cancer Therapeutics$436,402
U01 · FY2001 · CA
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$358,586
R37 · FY2001 · GM
ENDOTHELIAL HEPARAN SULFATE IN VASCULAR BIOLOGY$135,852
P01 · FY2001 · HL
SELECTIN/HEPARAN SULFATE INTERACTIONS IN ACUTE LUNG INJURY$40,863
P50 · FY2001 · HL
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$308,891
R37 · FY2000 · GM
GLYCOSIDE ANTAGONISTS OF GLYCOSYLATION$274,721
R01 · FY2000 · CA
ENDOTHELIAL HEPARAN SULFATE IN VASCULAR BIOLOGY$148,882
P01 · FY2000 · HL
SELECTIN/HEPARAN SULFATE INTERACTIONS IN ACUTE LUNG INJURY$148,366
P50 · FY2000 · HL
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM$13,562
R37 · FY2000 · GM